HomeAI · summaries
Storia in 11 fonti
Women on GLP-1 drugs 30 percent less likely to develop breast cancer
About 42,140 women are expected to die from breast cancer in the U.S. this year
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
sciencedaily.com
People taking GLP-1 weight loss drugs like Ozempic started moving less
People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers analyzing Fitbit data…
- ·
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.…
- ·
theguardian.com
Weight-loss drugs can cut breast cancer risk by up to 30%, studies suggest
Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease
- ·
abc.es
El uso de Ozempic se asocia con una reducción del 30 % en la incidencia de cáncer de mama
Un estudio observacional con más de 110 000 mujeres abre la puerta a utilizar estos populares medicamentos para la pérdida de peso como prevención oncológica.
- ·
independent.co.uk
Women on GLP-1 drugs 30 percent less likely to develop breast cancer
About 42,140 women are expected to die from breast cancer in the U.S. this year
- ·
GLP-1s may lower breast cancer risk in women by 30%, new study suggests
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWeight-loss jabs have risen in popularity…
- ·
newsbytesapp.com
Weight loss drugs can protect you from breast cancer
Weight-loss drugs may reduce breast cancer risk by up to 30%, according to three studies, highlighting their potential role in lowering cancer development and mortality rates.
- ·
abcnews.com
Doctor breaks down study showing GLP-1s may lower breast cancer risk
A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast cancer by about 30%.
- ·
channelnewsasia.com
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer
More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm…
- ·
euronews.com
Weight-loss drugs linked to lower breast cancer risk, study finds
Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study.
- ·
it.euronews.com
Studio: farmaci dimagranti riducono rischio di tumore al seno
Secondo un nuovo studio, le donne che assumono farmaci dimagranti potrebbero avere un rischio inferiore di sviluppare un tumore al seno.
- ·
medpagetoday.com
Accumulating Evidence Lifts GLP-1s to Clinical Trial for Breast Cancer Prevention
Use of drugs for overweight/obesity linked to lower risk of breast cancer, several leukemias
- ·
sciencealert.com
Popular Weight Loss Drugs Linked to Lower Risk of Breast Cancer
The potential benefits of GLP-1 drugs, like Ozempic or Wegovy, are stacking up.